Buy Micardis HCT

Micardis HCT

What is Micardis HCT?

Micardis HCT is a prescription pill that contains the two active ingredients telmisartan and hydrochlorothiazide. It belongs to the heart and blood-pressure therapeutic class and is approved for the treatment of hypertension. The combination is available in two strengths: 40 mg telmisartan / 12.5 mg hydrochlorothiazide and 80 mg telmisartan / 12.5 mg hydrochlorothiazide. In Hong Kong, Micardis HCT is regulated by the Pharmacy and Poisons Board and may only be dispensed with a valid prescription.

How Micardis HCT Works in the Body

• Telmisartan is an angiotensin II receptor blocker (ARB). By binding to the AT₁ receptor, it prevents angiotensin II from causing blood-vessel constriction, which lowers systemic vascular resistance and reduces blood pressure.
• Hydrochlorothiazide is a thiazide-type diuretic. It inhibits sodium-chloride reabsorption in the distal convoluted tubule, promoting the excretion of sodium, water, and potassium. This modest volume reduction further contributes to blood-pressure control.
• The two mechanisms act synergistically: telmisartan relaxes the vasculature while hydrochlorothiazide decreases fluid overload, offering a more consistent blood-pressure decline than either component alone.
• Onset of action for telmisartan occurs within 2 hours, with peak effect at about 6 hours; hydrochlorothiazide begins to work within 2 hours and reaches peak diuretic effect in 4-6 hours. Both agents have a duration of action that supports once-daily dosing.

Conditions Treated by Micardis HCT

• Primary hypertension in adults, when a single-agent regimen does not achieve target blood pressure.
• The medication is indicated for patients who require both an ARB and a thiazide diuretic to reach guideline-recommended blood-pressure goals (e.g., <130/80 mm Hg for most high-risk individuals).
• Micardis HCT may be considered in patients with isolated systolic hypertension, especially in older adults, as telmisartan’s vasodilatory effect is effective across a range of ages.

Who Should Not Use Micardis HCT?

Absolute contraindications

• Known hypersensitivity to telmisartan, hydrochlorothiazide, or any excipients in the pill.
• Pregnancy (especially the second and third trimesters) because ARBs can cause fetal toxicity, and thiazides may impair fetal kidney development.

Relative contraindications

• Severe renal impairment (eGFR < 30 mL/min/1.73 m²) or dialysis dependence.
• Hepatic cirrhosis with severe impairment of hepatic function.
• Hyperkalemia (serum potassium > 5.5 mmol/L) due to the potassium-sparing potential of ARBs.
• History of electrolyte disturbances (e.g., hyponatremia, hypokalemia) on thiazide therapy.

Special populations

• Pregnancy & lactation: Use is contraindicated; discuss alternative antihypertensives with a healthcare professional.
• Elderly: Initiate at the lower dose (40 mg/12.5 mg) and monitor renal function closely.
• Patients with gout: Hydrochlorothiazide can raise serum uric acid; monitor gout symptoms.

Safety Profile and Interactions

Common Side Effects

• Dizziness or light-headedness, especially after the first dose.
• Increased urination due to the diuretic component.
• Mild upper-respiratory tract infection symptoms.

Serious Adverse Events

• Significant hypotension leading to syncope.
• Acute kidney injury, particularly in patients with pre-existing renal disease or volume depletion.
• Hyperkalemia that may manifest as muscle weakness or cardiac arrhythmias.

Drug Interactions

• Potassium-sparing agents (e.g., spironolactone, amiloride): May raise serum potassium to dangerous levels; concurrent use requires close monitoring.
• Non-steroidal anti-inflammatory drugs (NSAIDs): Can blunt the antihypertensive effect and increase the risk of renal impairment.
• Lithium: Co-administration may increase lithium levels, raising the risk of toxicity.
• Other antihypertensives (e.g., ACE inhibitors, beta-blockers): May cause additive blood-pressure lowering; dose adjustments may be needed.

Food and Lifestyle Interactions

• No specific food restrictions, but a high-salt diet can diminish the diuretic’s effectiveness.
• Alcohol may increase the risk of orthostatic hypotension; limit intake and avoid excessive consumption.
• Patients should refrain from operating heavy machinery until they know how Micardis HCT affects their alertness.

How to Take Micardis HCT

• Standard dosing: One tablet taken orally once daily, preferably in the morning. The usual starting dose is 40 mg telmisartan / 12.5 mg hydrochlorothiazide; if blood pressure remains above target after 2-4 weeks, the dose may be increased to 80 mg / 12.5 mg.
• Administration details: Swallow the tablet whole with a full glass of water; it may be taken with or without food.
• Renal or hepatic impairment: Start with the lower dose and titrate cautiously; clinicians may adjust based on laboratory results.
• Missed dose: Take the missed tablet as soon as remembered, unless it is near the time of the next scheduled dose. Do not double the dose.
• Overdose: Symptoms may include severe hypotension, rapid heartbeat, or electrolyte imbalance. Seek emergency medical care; treatment is supportive and may involve intravenous fluids and electrolyte correction.
• Discontinuation: The medication can generally be stopped without tapering, but abrupt cessation may lead to a rebound increase in blood pressure. Discuss any changes with a prescriber.

Monitoring and Follow-Up

• Blood pressure: Measure at each clinic visit; aim for the target set by local hypertension guidelines (e.g., <130/80 mm Hg for most adults).
• Renal function: Serum creatinine and eGFR should be checked before initiation, after any dose increase, and periodically thereafter.
• Electrolytes: Sodium, potassium, and chloride levels are monitored, especially in the first few weeks and after dose adjustments.
• Liver enzymes: Baseline assessment is advisable; repeat if clinically indicated.
• Patients should contact their healthcare provider if they experience persistent dizziness, swelling, sudden weight gain, or signs of electrolyte imbalance.

Storage and Handling

• Keep the tablets in the original container, tightly closed, at room temperature (15-30 °C).
• Protect from moisture, heat, and direct sunlight.
• Do not use the medication after the expiry date printed on the package.
• Safely discard any unused tablets according to local pharmaceutical waste guidelines or return them to a pharmacy for proper disposal.

Medication-Specific Glossary

Angiotensin II Receptor Blocker (ARB)

A class of drugs that block the effects of angiotensin II on blood vessels, leading to vasodilation and reduced blood pressure.

Thiazide Diuretic

A medication that promotes the excretion of sodium and water by acting on the distal tubules of the kidney, thereby lowering circulating fluid volume.

Electrolyte Imbalance

A disturbance in the normal concentrations of minerals such as sodium, potassium, or chloride in the blood, which can affect heart rhythm and muscle function.

Medical Disclaimer

This article provides educational information about Micardis HCT and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.